These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37431844)

  • 81. Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients.
    Li Y; Ryu C; Munie M; Noorulla S; Rana S; Edwards P; Gao H; Qiao X
    J Diabetes Res; 2018; 2018():2801450. PubMed ID: 29854819
    [TBL] [Abstract][Full Text] [Related]  

  • 82. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic.
    Faruqi J; Balasubramanyam A
    Expert Rev Endocrinol Metab; 2023 Mar; 18(2):167-179. PubMed ID: 36797835
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus.
    Yen FS; Wang SI; Lin SY; Wei JC
    Diabetes Res Clin Pract; 2023 Jun; 200():110692. PubMed ID: 37156428
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021.
    Barrett CE; Koyama AK; Alvarez P; Chow W; Lundeen EA; Perrine CG; Pavkov ME; Rolka DB; Wiltz JL; Bull-Otterson L; Gray S; Boehmer TK; Gundlapalli AV; Siegel DA; Kompaniyets L; Goodman AB; Mahon BE; Tauxe RV; Remley K; Saydah S
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):59-65. PubMed ID: 35025851
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer.
    Linkeviciute-Ulinskiene D; Patasius A; Kincius M; Zabuliene L; Smailyte G
    Scand J Urol; 2020 Oct; 54(5):401-407. PubMed ID: 32748714
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
    Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA
    Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss.
    Behera J; Ison J; Voor MJ; Tyagi SC; Tyagi N
    Biochem Biophys Res Commun; 2022 Sep; 620():180-187. PubMed ID: 35803174
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients' susceptibility to COVID-19 to the possible caution of future global diabetes tsunami.
    Sharbatdar Y; Mousavian R; Noorbakhsh Varnosfaderani SM; Aziziyan F; Liaghat M; Baziyar P; Yousefi Rad A; Tavakol C; Moeini AM; Nabi-Afjadi M; Zalpoor H; Kazemi-Lomedasht F
    Inflammopharmacology; 2023 Jun; 31(3):1029-1052. PubMed ID: 37079169
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study.
    Mahrooz A; Parsanasab H; Hashemi-Soteh MB; Kashi Z; Bahar A; Alizadeh A; Mozayeni M
    Clin Exp Med; 2015 May; 15(2):159-65. PubMed ID: 24740684
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong.
    Luk AOY; Yip TCF; Zhang X; Kong APS; Wong VW; Ma RCW; Wong GL
    BMJ Open; 2021 Oct; 11(10):e052310. PubMed ID: 34670765
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
    Bramante CT; Huling JD; Tignanelli CJ; Buse JB; Liebovitz DM; Nicklas JM; Cohen K; Puskarich MA; Belani HK; Proper JL; Siegel LK; Klatt NR; Odde DJ; Luke DG; Anderson B; Karger AB; Ingraham NE; Hartman KM; Rao V; Hagen AA; Patel B; Fenno SL; Avula N; Reddy NV; Erickson SM; Lindberg S; Fricton R; Lee S; Zaman A; Saveraid HG; Tordsen WJ; Pullen MF; Biros M; Sherwood NE; Thompson JL; Boulware DR; Murray TA;
    N Engl J Med; 2022 Aug; 387(7):599-610. PubMed ID: 36070710
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Metformin reduces the increased risk of oral squamous cell carcinoma recurrence in patients with type 2 diabetes mellitus: A cohort study with propensity score analyses.
    Hu X; Xiong H; Chen W; Huang L; Mao T; Yang L; Wang C; Huang D; Wang Z; Yu J; Shu Y; Xia K; Su T
    Surg Oncol; 2020 Dec; 35():453-459. PubMed ID: 33065527
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study.
    Soliman AT; Prabhakaran Nair A; Al Masalamani MS; De Sanctis V; Abu Khattab MA; Alsaud AE; Sasi S; Ali EA; Ola A H; Iqbal FM; Nashwan AJ; Fahad J; El Madhoun I; Yassin MA
    Acta Biomed; 2020 Sep; 91(3):e2020010. PubMed ID: 32921708
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
    Lin SY; Tu HP; Lu PL; Chen TC; Wang WH; Chong IW; Chen YH
    Respirology; 2018 Nov; 23(11):1063-1073. PubMed ID: 29943489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.